Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

$BLDR, $CRL, $COST, $ILMN, $INNT

Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of Wall Street’s Top analysts outlook for Key issues for Wednesday, as follows:

Builders FirstSource Inc. (NASDAQ:BLDR) was maintained as Outperform but the price target was cut to 27 from 30 at Wedbush Securities.

Charles River Laboratories International Inc. (NYSE:CRL) was raised to Outperform from Sector Perform with a 131 price target at RBC Capital Markets.

Costco Wholesale Corp. (NASDAQ:COST) was reiterated as Outperform and the price target was raised to 225 from 205 at Raymond James.

Illumina Inc. (NASDAQ:ILMN) was reiterated as Overweight and the price target was raised to 327 from 272 at Piper Jaffray.

Innovative BioPharma Inc. (NASDAQ:INNT) was started with a Buy rating and assigned a $35 price target at HC Wainwright.

Stay tuned…

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

Latest posts by Paul Ebeling (see all)

You must be logged in to post comments :  
CONNECT WITH